Quinoa: fewer progressions to diabetes in people with impaired glucose tolerance, slightly lower blood glucose and triglycerides in trials; on weight, meta-analyses diverge.
“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.

Pom² · CC BY-SA 3.0
From 25 to 100 g per day in trials, over 4 weeks to one year.
Limitations: weight: a meta-analysis of 5 trials found 1.26 kg less, another of 7 trials no effect on weight or BMI. In 148 overweight adults, 40 g per day of quinoa for 4 weeks did no better than buckwheat, bulgur or rice. In 28 men, quinoa-enriched bread changed nothing in the gut microbiota in 4 weeks. Americans who eat quinoa have lower weight and triglycerides, but also an overall better diet, which may explain this. Trials are small or short-term, except for two one-year trials on people with impaired glucose tolerance.
Quinoa contains ecdysterone, classified as an anabolic agent and monitored by the World Anti-Doping Agency since 2020: in eight people who had eaten about 368 g of cooked quinoa, only 2.61 % was found in the urine. Quinoa is a poorly assimilated source of it.
This meta-analysis, based on 7 randomized controlled trials (258 adults), evaluated the effects of quinoa consumption on fasting blood glucose, body weight, and BMI. It revealed significant beneficial effects of quinoa on fasting blood glucose, with a more pronounced improvement around a consumption of 25g per day. However, no significant difference was observed for body weight or BMI compared to the placebo.
Atefi M, Heidari Z, Shojaei M, Askari G, Kesharwani P, Bagherniya M, Sahebkar A. — Current medicinal chemistry (2024) — View the source study
For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more